Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Data submission Proride 140825

ABSTRACT: This is an untargeted fecal metabolomic dataset of Tanzanian infants at 6 weeks and 6 months which have either recevied probiotics or placebo. The data has been generated using the Thermo Acquire X.

INSTRUMENT(S): Orbitrap ID-X

ORGANISM(S): Uncultured Fecal Microbiome

SUBMITTER: Veronika K. Pettersen

PROVIDER: MSV000098821 | MassIVE | Thu Aug 14 00:11:00 BST 2025

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Beneficial effect of probiotic supplements in Gastroesophageal reflux disease treated with Rabeprazole: a double-blind, randomized, placebo-controlled study

Project description:In this study we conducted a randomized, double-blind, placebo-controlled trial to evaluate the effects of administering probiotic mixtures containing Lactobacillus casei Zhang, Bifidobacterium lactis V9, and Lactobacillus plantarum P9 in patients with GERD. Patients were randomized into probiotic and placebo groups . All patients were treated with rabeprazole tablets and simultaneously received either probiotic or placebo for 8 weeks, and then administrated with probiotic or placebo alone for 4 weeks. Fecal samples from patients were collected and analyzed by untargeted metabolomics at weeks 0, 4, 8, 12.

| MSV000095809 | MassIVE

Probiotics-Mediated Reduction of Inflammatory Gut-Bacteria Improves MASLD via Fecal Lipidome Remodeling

Project description:This dataset contains raw high-resolution mass spectrometry data from a randomized controlled trial evaluating probiotic supplementation in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) (ClinicalTrials.gov Identifier: NCT04555434). Participants received placebo or probiotic capsules containing Pediococcus pentosaceus, Lactobacillus lactis, or Lactobacillus helveticus for 8 weeks. Fecal samples collected before and after intervention from participants with high medication adherence (at least 98%) were analyzed using untargeted metabolomic and lipidomic profiling. The data capture probiotic-associated alterations in fecal metabolites and lipid species related to gut-liver axis modulation and hepatic function.

2026-02-22 | MSV000100934 | MassIVE

MPRINT clinical study - feces - mother-infant pairs ABX exposure

Project description:Fecal samples collected from mothers and their infants (United States). Mothers received antibiotics based on clinical indication or served as untreated controls. Untargeted LC-MS/MS acquisition was performed on a Vanquish ultra-high-performance liquid chromatography (UHPLC) system coupled to a QExactive Orbitrap (Thermo Scientific) mass spectrometer.

2025-11-16 | MSV000099924 | MassIVE

Infant Circulating MicroRNAs as Biomarkers of Effect in Fetal Alcohol Spectrum Disorders

Project description:Infant plasma miRNAs were isolated at 2 weeks and 6.5 months of age from prenatal alcohol exposed and control infants

2021-01-14 | GSE164209 | GEO

Multiomic Profiling of Iron Deficient Infant Monkeys Reveals Alterations in Neurologically Important Biochemicals in Serum and CSF Prior to the Onset of Anemia

Project description:Background: The effects of iron deficiency anemia (IDA) during infancy extend beyond the hematologic compartment and include short- and long-term adverse effects on many tissues including the brain. However, biomarkers of iron-dependent brain health are lacking in humans. Prior analyses in rhesus infants indicated abnormal serum and cerebral spinal fluid (CSF) multiomic profiles both prior to and during IDA, characterized by alterations suggestive of hepatic and brain metabolic dysfunction, and impaired energy metabolism. Objective: To determine whether serum and CSF biomarkers of iron deficiency (ID)-induced metabolic dysfunction are concordant in the pre/early anemic stage of ID in a nonhuman primate model of infantile IDA. Methods: Paired serum and CSF specimens were collected from iron-sufficient (IS; n = 12) and ID (n = 7) rhesus infants at 4-months (preanemic period) and 6-months (anemic period) of age. Hematological, metabolomic, and proteomic profiles were generated via HPLC/MS at both timepoints to discover serum biomarkers of ID-induced brain metabolic dysfunction. Results: We identified and quantified 227 metabolites and 205 proteins in serum. Abnormalities indicating altered liver function, lipid dysregulation, and increased acute phase proteins were present in ID. In CSF, we measured 210 metabolites and 1,560 proteins with ID infants displaying metabolomic and proteomic changes indicating disrupted synaptogenesis. Concurrent systemic and CSF proteomic and metabolomic changes were present in the preanemic and anemic periods. Conclusions: Multiomic serum and CSF profiling uncovered pathways disrupted by ID in both the preanemic and anemic stages of infantile IDA, including evidence for liver metabolic dysfunction and acute phase responses. Parallel changes observed in serum and CSF potentially provide measurable serum biomarkers that reflect at-risk brain processes early during ID.

2022-03-18 | PXD028275 | Pride

Effect of Lira treatment on heart in obese mice

2012-12-25 | GSE25515 | GEO

Airway epithelial cells from smokers treated with myo-inositol or placebo

Project description:Samples were obtained as part of a randomized, double blind, placebo-controlled, phase IIb study to determine the effects of myo-inositol in smokers with bronchial dysplasia. Smokers with greater than 1 site of dysplasia identified by autofluorescence bronchoscopy-directed biopsy were randomly assigned to receive oral placebo or myo-inositol, 9 g once/day for two weeks and then twice/day for 6 months. Cytologically normal airway epithelial cells were obtained via bronchoscopy from the right or left mainstem bronchus at baseline and 6 months post-treatment with myo-inositol or placebo from 69 study participants (n=138 samples). The RNA from these samples was isolated and used to prepare libraries for mRNA sequencing. Subjects were classified by response according to their change in dysplasia rate after 6-months. Among subjects with a complete response in the myo-inositol arm, there was a significant decrease in a gene expression signature reflective of PI3K activation.

2016-09-26 | GSE86422 | GEO

Effect of Lira treatment on heart in obese mice

Project description:C57BL/6 Male mice were treated with high fat diet at the age of 8 weeks and continue the diet for 16 weeks(4 mo) and then injected them with placebo/drug for 1 week before sacrifice. Their were sacrifised at the age of 6 months. Drug: Lira is used to reduce morbidity and mortality due to obesity and its effect on heart. 10 C57BL/6 Male mice under high fat diet for 16 weeks treated with either Placebo/drug were chosen for the microarray analysis. Heart from each mouse was disected and the left ventricle was used for TRNA extraction.

2012-12-25 | E-GEOD-25515 | biostudies-arrayexpress

Early Life microbiome

Project description:Fecal and breastmilk microbiome from a cohort of 93 infants. Fecal microbiome was sampled at 2 weeks, 6 weeks, 3 months and 6 months. Breastmilk microbiome of the mothers was sampled at 6 weeks. Microbiome composition was analyzed using 16S rRNA sequencing (Illumina Miseq).

| PRJEB50418 | ENA

LC-MS metabolomics dataset from fecal microbiota transplantation experiments in a food allergy

Project description:Untargeted metabolomic analysis of serum and fecal samples was performed to investigate microbial metabolites associated with tolerance induction following fecal microbiota transplantation (FMT) in human subjects and microbiome-transplanted mice.

2026-03-10 | MSV000101091 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data